mortality/aging
• all mice become ill, showing decreased spontaneous movements, increased respiratory rates, piloerection and shivering, and die between 12 and 22 months
|
behavior/neurological
• ill mice show piloerection
|
• ill mice show decreased spontaneous movements
|
hematopoietic system
• B-cells show increased proliferation to anti-IgM antibody, although B-cell proliferation is similar to controls at saturating anti-IgM antibody concentrations, indicating that B-lymphocytes show enhanced sensitivity to surface Ig stimulation
|
• older mice show a decrease in B-1 cell number and percentage in the spleen
• however, no difference in the number and percentage of B-1 and B-1a cells in the bone marrow and peritoneum
|
• older mice show an increase in B-1 cell number in the lymph nodes
|
• splenic sinusoids are dilated and distorted by large quantities of proteinaceous deposits, which are also present surrounding small and medium-caliber splenic blood vessels
|
• massive splenomegaly
|
• a large proportion of the expanded white pulp represents B cells and slightly smaller proportion of T cells
• white pulp expansions represent lymphoid hyperplasia, without germinal center formation
|
• non-immunized mice produce antibodies of all isotypes and IgG titers tend to be higher, with a statistical difference for IgG1
|
homeostasis/metabolism
amyloidosis
(
J:221238
)
• proteinaceous deposits are found adjacent to expanded white-pulp areas and in multiple organs, including kidney, liver, lung and small intestine, that are consistent with amyloid deposition
• intestine shows massive amyloid deposition
• massive amyloid deposition is seen in all renal glomeruli, as well as the interstitium
• amyloid deposition is seen surrounding small and medium caliber blood vessels in the kidneys, lung, and liver, but not the heart
• the most abundant protein in the amyloid deposits is serum amyloid-associated protein-2, consistent with amyloid A amyloidosis
|
immune system
• B-cells show increased proliferation to anti-IgM antibody, although B-cell proliferation is similar to controls at saturating anti-IgM antibody concentrations, indicating that B-lymphocytes show enhanced sensitivity to surface Ig stimulation
|
• older mice show a decrease in B-1 cell number and percentage in the spleen
• however, no difference in the number and percentage of B-1 and B-1a cells in the bone marrow and peritoneum
|
• older mice show an increase in B-1 cell number in the lymph nodes
|
• splenic sinusoids are dilated and distorted by large quantities of proteinaceous deposits, which are also present surrounding small and medium-caliber splenic blood vessels
|
• massive splenomegaly
|
• a large proportion of the expanded white pulp represents B cells and slightly smaller proportion of T cells
• white pulp expansions represent lymphoid hyperplasia, without germinal center formation
|
• non-immunized mice produce antibodies of all isotypes and IgG titers tend to be higher, with a statistical difference for IgG1
|
• starting at 12 months of age, mice show increased-sized Peyer's patches
|
• polyclonal follicular B-cell lymphoid hyperplasia
|
• kidney, liver, and lung show modest mixed lymphoid infiltrates
|
respiratory system
• in ill mice
|
cellular
• B-cells show increased proliferation to anti-IgM antibody, although B-cell proliferation is similar to controls at saturating anti-IgM antibody concentrations, indicating that B-lymphocytes show enhanced sensitivity to surface Ig stimulation
|
growth/size/body
• massive splenomegaly
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
amyloidosis | DOID:9120 | J:221238 |